Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for persistent, recurrent, or metastatic cervical cancer: Randomized, double-blind, phase III KEYNOTE-826 study


Colombo N., Dubot C., Lorusso D., Caceres V., Hasegawa K., Shapira-Frommer R., ...More

ANNALS OF ONCOLOGY, vol.32, 2021 (Journal Indexed in SCI) identifier

  • Publication Type: Article / Abstract
  • Volume: 32
  • Publication Date: 2021
  • Doi Number: 10.1016/j.annonc.2021.08.2108
  • Title of Journal : ANNALS OF ONCOLOGY